Interstitial needles versus intracavitary applicators only for locally advanced cervical cancer: results from real-life dosimetric comparisons - Centre Oscar Lambret
Article Dans Une Revue Frontiers in Oncology Année : 2024

Interstitial needles versus intracavitary applicators only for locally advanced cervical cancer: results from real-life dosimetric comparisons

Résumé

Background and purpose Image-guided adapted brachytherapy (IGABT) is superior to other radiotherapy techniques in the treatment of locally advanced cervical cancer (LACC). We aimed to investigate the benefit of interstitial needles (IN) for a combined intracavitary/interstitial (IC/IS) approach using IGABT over the intracavitary approach (IC) alone in patients with LACC after concomitant external beam radiotherapy (EBRT) and chemotherapy. Materials and methods We included consecutive patients with LACC who were treated with IC/IS IGABT after radiochemotherapy (RCT) in our retrospective, observational study. Dosimetric gain and sparing of organs at risk (OAR) were investigated by comparing the IC/IS IGABT plan with a simulated plan without needle use (IC IGABT plan) and the impact of other clinical factors on the benefit of IC/IS IGABT. Results Ninety-nine patients were analyzed, with a mean EBRT dose of 45.5 ± 1.7 Gy; 97 patients received concurrent chemotherapy. A significant increase in median D90% High Risk Clinical target volume (HR-CTV) was found for IC/IS (82.8 Gy) vs IC (76.2 Gy) (p < 10 -4 ). A significant decrease of the delivered dose for all OAR was found for IC/IS vs IC for median D2 cc to the bladder (77.2 Gy), rectum (68 Gy), sigmoid (53.2 Gy), and small bowel (47 Gy) (all p < 10 -4 ). Conclusion HR-CTV coverage was higher with IC/IS IGABT than with IC IGABT, with lower doses to the OAR in patients managed for LACC after RCT. Interstitial brachytherapy in the management of LACC after radiotherapy provides better coverage of the target volumes, this could contribute to better local control and improved survival of patients.
Fichier principal
Vignette du fichier
2024_LeDeley_FrontOncol.pdf (733.88 Ko) Télécharger le fichier
Origine Publication financée par une institution
licence

Dates et versions

inserm-04659922 , version 1 (23-07-2024)

Licence

Identifiants

Citer

Abel Cordoba, Estelle Gesta, Alexandre Escande, Alexandra Noeuveglise, Romain Cayez, et al.. Interstitial needles versus intracavitary applicators only for locally advanced cervical cancer: results from real-life dosimetric comparisons. Frontiers in Oncology, 2024, 14, pp.1347727. ⟨10.3389/fonc.2024.1347727⟩. ⟨inserm-04659922⟩
18 Consultations
9 Téléchargements

Altmetric

Partager

More